Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

PANORAMA 1 study evaluates panobinostat in multiple myeloma

Dec. 16, 2011

Avila Therapeutics product shows promise to treat hematological cancers

Dec. 15, 2011

Novel antimalarial is potent without inducing parasite dormancy

Dec. 15, 2011

Antitumor effects of K-560 evaluated in preclinical settings

Dec. 15, 2011

Second remissions evaluated in epratuzumab study in relapsed acute lymphoblastic leukemia

Dec. 15, 2011

New biomarker for dengue fever identified

Dec. 15, 2011

ArQule and Daiichi Sankyo disclose preclinical findings on ARQ-092

Dec. 15, 2011

Eisai reports new agents with antitumor potential

Dec. 14, 2011

CSF-1-R-targeted antibody shows promise in proof-of-principle study

Dec. 14, 2011

First data reported on Graspa in older patients with Ph- ALL

Dec. 14, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...